2025-04-08 17:34:27
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Concord Drugs Ltd Q4FY21 net profit drops QoQ to Rs. 33.567 lakhs
Posted On : 2021-06-28 22:46:10( TIMEZONE : IST )
Concord Drugs Ltd has reported financial results for the period ended March 31, 2021.
Financial Results (Q4 FY20-21) - QoQ Comparison
The company has reported total income of Rs.8.36 crores during the period ended March 31, 2021 as compared to Rs.8.24 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.0.33567 crores for the period ended March 31, 2021 as against net profit / (loss) of Rs.2.69 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.0.38 for the period ended March 31, 2021 as compared to Rs.3.09 for the period ended December 31, 2020.
| Financials | Q4 FY20-21 | Q3 FY20-21 | % Change |
| Total Income | ₹ 8.36 crs | ₹ 8.24 crs |  1.46% |
| Net Profit | ₹ 0.33567 crs | ₹ 2.69 crs |  -87.52% |
| EPS | ₹ 0.38 | ₹ 3.09 | -87.7% |
Financial Results (Q4 FY20-21) - YoY Comparison
The company has reported total income of Rs.8.36 crores during the period ended March 31, 2021 as compared to Rs.13.07 crores during the period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.0.33567 crores for the period ended March 31, 2021 as against net profit / (loss) of Rs.0.1172 crores for the period ended March 31, 2020.
The company has reported EPS of Rs.0.38 for the period ended March 31, 2021 as compared to Rs.0.13 for the period ended March 31, 2020.
| Financials | Q4 FY20-21 | Q4 FY19-20 | % Change |
| Total Income | ₹ 8.36 crs | ₹ 13.07 crs | -36.04% |
| Net Profit | ₹ 0.33567 crs | ₹ 0.1172 crs | 186.41% |
| EPS | ₹ 0.38 | ₹ 0.13 | 192.31% |
Financial Results (Year ended FY 20-21) - YoY Comparison
The company has reported total income of Rs.51.45 crores during the 12 months period ended March 31, 2021 as compared to Rs.51.45 crores during the 12 months period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.3.28 crores for the 12 months period ended March 31, 2021 as against net profit / (loss) of Rs.0.32826 crores for the 12 months period ended March 31, 2020.
The company has reported EPS of Rs.3.75 for the 12 months period ended March 31, 2021 as compared to Rs.0.38 for the 12 months period ended March 31, 2020.
| Financials | Year Ended FY20-21 | Year Ended FY19-20 | % Change |
| Total Income | ₹ 51.45 crs | ₹ 51.45 crs | 0% |
| Net Profit | ₹ 3.28 crs | ₹ 0.32826 crs | 899.21% |
| EPS | ₹ 3.75 | ₹0.38 | 886.84% |
Shares of Concord Drugs Ltd was last trading in BSE at Rs.32.95 as compared to the previous close of Rs. 32.55. The total number of shares traded during the day was 6939 in over 66 trades.
The stock hit an intraday high of Rs. 33 and intraday low of 32. The net turnover during the day was Rs. 225339.
